MX2019006084A - Farmaco para tratar la adiccion a la cocaina o prevenir la recurrencia de la misma. - Google Patents

Farmaco para tratar la adiccion a la cocaina o prevenir la recurrencia de la misma.

Info

Publication number
MX2019006084A
MX2019006084A MX2019006084A MX2019006084A MX2019006084A MX 2019006084 A MX2019006084 A MX 2019006084A MX 2019006084 A MX2019006084 A MX 2019006084A MX 2019006084 A MX2019006084 A MX 2019006084A MX 2019006084 A MX2019006084 A MX 2019006084A
Authority
MX
Mexico
Prior art keywords
drug
same
cocaine addiction
treating cocaine
preventing recurrence
Prior art date
Application number
MX2019006084A
Other languages
English (en)
Inventor
Teshima Koji
Original Assignee
Mitsubishi Tanabe Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Tanabe Pharma Corp filed Critical Mitsubishi Tanabe Pharma Corp
Publication of MX2019006084A publication Critical patent/MX2019006084A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invencion proporciona un farmaco para tratar la adiccion a la cocaina o prevenir la recaida de la misma; especificamente, la presente invencion proporciona un farmaco para tratar la adiccion a la cocaina o prevenir la recaida de la misma que contiene (R)-2-{3-[1-(5-metil- 1,2,3,4-tetrahidronaftale n-1-il)piperidin-4-il]-2,3-dihidro-2-oxo-bencimidazol-1-il}-N-met ilacetamida o una sal farmaceuticamente aceptable de la misma.
MX2019006084A 2016-11-28 2017-11-27 Farmaco para tratar la adiccion a la cocaina o prevenir la recurrencia de la misma. MX2019006084A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662426748P 2016-11-28 2016-11-28
PCT/JP2017/042425 WO2018097291A1 (ja) 2016-11-28 2017-11-27 コカイン依存症の治療または再発予防薬

Publications (1)

Publication Number Publication Date
MX2019006084A true MX2019006084A (es) 2019-11-12

Family

ID=62195874

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019006084A MX2019006084A (es) 2016-11-28 2017-11-27 Farmaco para tratar la adiccion a la cocaina o prevenir la recurrencia de la misma.

Country Status (13)

Country Link
US (1) US11058674B2 (es)
EP (1) EP3545955A4 (es)
JP (1) JPWO2018097291A1 (es)
KR (1) KR20190092464A (es)
CN (1) CN110139650A (es)
AU (1) AU2017364801A1 (es)
BR (1) BR112019010719A2 (es)
CA (1) CA3044950A1 (es)
IL (1) IL266866A (es)
MX (1) MX2019006084A (es)
PH (1) PH12019501165A1 (es)
RU (1) RU2019120099A (es)
WO (1) WO2018097291A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024007670A1 (en) * 2022-07-07 2024-01-11 Pharward Biotechnology, Inc. Pte. Ltd. Method for treating cocaine addiction

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1049689T3 (da) * 1998-01-19 2002-07-22 Pfizer 4-(2-keto-1-benzimidazolinyl)piperidinderivater som ORL1-receptoragonister
ES2541133T3 (es) 2007-03-01 2015-07-16 Mitsubishi Tanabe Pharma Corporation Compuesto de bencimidazol y uso farmacéutico del mismo

Also Published As

Publication number Publication date
PH12019501165A1 (en) 2019-10-28
RU2019120099A (ru) 2020-12-30
EP3545955A4 (en) 2020-07-29
AU2017364801A1 (en) 2019-06-20
US11058674B2 (en) 2021-07-13
IL266866A (en) 2019-08-29
WO2018097291A1 (ja) 2018-05-31
EP3545955A1 (en) 2019-10-02
US20200289492A1 (en) 2020-09-17
JPWO2018097291A1 (ja) 2019-10-17
BR112019010719A2 (pt) 2019-10-01
KR20190092464A (ko) 2019-08-07
CN110139650A (zh) 2019-08-16
CA3044950A1 (en) 2018-05-31

Similar Documents

Publication Publication Date Title
IL289793A (en) Heterocyclic compounds as ret kinase inhibitors
IL247833A0 (en) 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-converted-pyridin-2-yl)-3-(1h-tetrazol-1-yl)propan-2-ols and processes for their preparation
MY196243A (en) Dihydropyrimidine Compounds and Their Application In Pharmaceuticals
WO2016011390A8 (en) Irak4 inhibiting agents
SA520411990B1 (ar) مركبات مفيدة لتثبيط إنزيم كيناز 7 المعتمد على السيكلين
ZA201606386B (en) 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-substituted-pyridin-2-yl)-3-(1h-tetrazol-1-yl)propan-2-ols and processes for their preparation
PL3426250T3 (pl) Leczenie pacjenta lekiem będącym substratem CYP3A4 przeciwwskazanym do jednoczesnego podawania z silnym inhibitorem CYP3A4
HUE060082T2 (hu) Heterociklusos vegyületek, mint RET kináz inhibitorok
MX2017013797A (es) Inhibidor de janus quinasa.
MA39749A (fr) Dérivés de pipéridine-dione
SI3357922T1 (sl) 2-((5-(1-(3-(metilsulfonil)propil)piperidin-4-il)piridin-2-il)amino) pirido(2,3-D)pirimidin-7(8H)-on derivati in sorodne spojine kot CDK4 inhibitorji za zdravljenje tumorjev
MX2016012687A (es) Derivados de 2,4-tiazolidindiona en el tratamiento de trastornos del sistema nervioso central.
MY190849A (en) Methods of treating multiple sclerosis
EP3504204A4 (en) INDAZOLYL-L, 2,4-THIADIAZOLAMINE AND RELATED COMPOUNDS FOR INHIBITING RHO-ASSOCIATED PROTEIN KINASES AND FOR TREATING DISEASES
MX2017003294A (es) Quinolinas carboxamidas para usarse en el tratamiento de mielomas multiples.
NZ732704A (en) Quinoline carboxamides for use in the treatment of leukemia
MX2019006084A (es) Farmaco para tratar la adiccion a la cocaina o prevenir la recurrencia de la misma.
EP3541797A4 (en) 4 - ((6- (2- (2,4-DIFLUORPHENYL) -1,1-DIFLUOR-2-HYDROXY-3- (5-MERCAPTO-1H
IL272562B1 (en) Compounds or pharmaceutically acceptable salts thereof for the treatment of mycobacterial infection
EP3755701A4 (en) HETEROCYCLIC COMPOUNDS AS A MEANS AGAINST MALARIA AND THEIR PRODUCTION
AU2024203236A1 (en) Heterocyclic compounds as RET kinase inhibitors
PL3153022T3 (pl) N-(3’,4’-dichloro-5-metoksybifenyl-2-ylo)-3-(difluorometylo)-1-metylo-1H-pirazolo-4-karboksyamid